⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19853007 | 1.00 | — | — | |
| SCHEMBL4789886 | 1.00 | — | — | |
| SCHEMBL19853014 | 1.00 | — | — | |
| SCHEMBL1931507 | 1.00 | — | — | |
| SCHEMBL19853037 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL22491838 | 0.98 | CYP2D6 (0.56) | — | |
| SCHEMBL24690879 | 0.81 | — | — | |
| SCHEMBL21768270 | 0.79 | TSHR (0.50) | — | |
| SCHEMBL1318333 | 0.79 | SLC1A2 (0.45) | — | |
| SCHEMBL21768278 | 0.79 | TSHR (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115109795-A | Recombinant human III-type collagen injection and application thereof in skin collagen regeneration | 浙江双糖生物科技有限公司 | 2022-09-27 | — | — | CN | claimed |
| EP-3204029-A1 | IMPROVED PEPTIDE INHIBITORS OF SODIUM CHANNELS | The University of North Carolina at Chapel Hill (US) | 2017-08-16 | — | — | EP | claimed |
| WO-2016057795-A1 | IMPROVED PEPTIDE INHIBITORS OF SODIUM CHANNELS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2016-04-14 | — | — | WO | claimed |
| US-20250345370-A1 | MICROBIAL LIBERATION OF N-METHYLSEROTONIN FROM ORANGE FIBER | WASHINGTON UNIVERSITY (US) | 2025-11-13 | — | — | US | disclosed |
| US-20240294928-A1 | ARTIFICIAL NUCLEIC ACID MOLECULES | CureVac SE (DE) | 2024-09-05 | — | — | US | disclosed |
| CN-118064483-A | Application of colorless green algae 4-proline hydroxylase in preparation of hydroxylation modified recombinant collagen | 中山大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-118050510-A | Application of lysine hydroxylase serving as action target in preparation of medicament for treating urethral fibrosis | 中南大学湘雅二医院 | 2024-05-17 | — | — | CN | disclosed |
| CN-114717200-B | Marek's disease virus super virulent strain and construction and application of gene deletion strain thereof | 河南省农业科学院 | 2023-03-24 | — | — | CN | disclosed |
| CN-115785124-A | KRAS G12D inhibitors and uses thereof | 润佳（苏州）医药科技有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115109795-A | Recombinant human III-type collagen injection and application thereof in skin collagen regeneration | 浙江双糖生物科技有限公司 | 2022-09-27 | — | — | CN | disclosed |
| US-20220252594-A1 | GAMMA-DELTA T CELL LIGANDS FOR CANCER IMMUNOTHERAPY | THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2022-08-11 | — | — | US | disclosed |
| US-20050209181-A1 | Analyzing differential gene expression; mood/behavioral disorders; psychosis; drug screening | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2005-09-22 | — | — | US | disclosed |
| EP-1549771-A2 | METHOD FOR DIAGNOSING PANCREATIC CANCER | Oncotherapy Science, Inc. (JP) | 2005-07-06 | — | — | EP | disclosed |
| EP-1545580-A2 | NEW THERAPEUTIC USES OF TRI-, TETRA-, PENTA-, AND POLYPEPTIDES | Innapharma, Inc. (US) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004031412-A2 | METHOD FOR DIAGNOSING PANCREATIC CANCER | ONCOTHERAPY SCIENCE, INC. (JP) | 2004-04-15 | — | — | WO | disclosed |
| WO-2003087137-A2 | NEW THERAPEUTIC USES OF TRI-, TETRA-, PENTA-, AND POLYPEPTIDES | INNAPHARMA, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| WO-2000014201-A1 | POLYPEPTIDES CONTAINING MODIFIED, NON-NATURAL AMINO ACIDS AND METHODS OF PRODUCTION | UNITED STATES SURGICAL CORPORATION (US) | 2000-03-16 | — | — | WO | disclosed |
| WO-1999022758-A1 | TRI-, TETRA-, PENTA-, AND POLYPEPTIDES AND THEIR THERAPEUTIC USE AS AN ANTIDEPRESSANT AGENT | INNAPHARMA, INC. (US) | 1999-05-14 | — | — | WO | disclosed |
| EP-0824352-A1 | CYCLODEXTRIN COMPOUNDS AND METHODS OF MAKING AND USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996031220-A1 | CYCLODEXTRIN COMPOUNDS AND METHODS OF MAKING AND USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1996-10-10 | — | — | WO | disclosed |